Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4570176013 | Agalsidase alfa-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4570177016 | Product containing agalsidase alfa in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Agalsidase alfa-containing product in parenteral dose form | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Agalsidase alfa-containing product in parenteral dose form | est un(e) (attribut) | Product containing agalsidase alfa (medicinal product) | true | Inferred relationship | Some | ||
| Agalsidase alfa-containing product in parenteral dose form | a pour principe actif (attribut) | Agalsidase alfa (substance) | true | Inferred relationship | Some | 1 | |
| Agalsidase alfa-containing product in parenteral dose form | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Agalsidase alfa only product in parenteral dose form | est un(e) (attribut) | True | Agalsidase alfa-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR